MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹381 Cr | ₹314 Cr | ₹266 Cr | ₹185 Cr | ₹236 Cr |
What is the latest Consolidated Net Profit of MARKSANS PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹381 Cr |
Mar2024 | ₹314 Cr |
Mar2023 | ₹266 Cr |
Mar2022 | ₹185 Cr |
Mar2021 | ₹236 Cr |
How is Consolidated Net Profit of MARKSANS PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹381 Cr | 21.32 | |
Mar2024 | ₹314 Cr | 17.80 | |
Mar2023 | ₹266 Cr | 44.29 | |
Mar2022 | ₹185 Cr | -21.77 | |
Mar2021 | ₹236 Cr | - |
Compare Consolidated Net Profit of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹10,333.0 Cr | -7.8% | -7.7% | 12.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -7.8% |
-7.7% |
12.9% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses